CD4 and neoplasm: Interestingly, Scy1 is highly upregulated in the CD4+ cells stimulated by tumour-derived antigens, resulting in induction of a regulatory phenotype of the T cell (Treg), which suggests its potential role in the tolerance mechanism during tumour development (Getnet et al., 2009).